Medical cannabis

The request was partially successful.

Dear Department of Health,

Could you please advice me what actions you currently are undertaking to determine the clear health benifits of cannabis, any studies that are presently being conducted on behalf of the helth department or under liscense by.

Yours faithfully, Darryl Noe jr

Do Not Reply,

Our ref: DE-1025761  

 

Dear  Mr Noe,
 
Thank you for your correspondence of 23 March about cannabis for medicinal
uses.  I have been asked to reply.

 

I should explain that the Freedom of Information Act only applies to
recorded information such as paper or electronic archive material.  As
your correspondence asked for general information, rather than requesting
recorded information or documentation, it did not fall under the
provisions of the Act.

 

Cannabis and its preparations, such as cannabis oil, which contain the
controlled substance tetrahydrocannabinol, are Class B controlled drugs
under the Misuse of Drugs Act 1971.  Cannabis is also subject to
international drug control under UN Conventions. 

 

The Misuse of Drugs Act 1971, and regulations made under the Act, allow
for controlled drugs to be used as medicines.  For example, Sativex, a
cannabis-based drug used to treat moderate to severe spasticity in
multiple sclerosis, was rescheduled following the granting of a marketing
authorisation to enable its prescribing and use as a medicine in the UK.

 

The National Institute for Health Research (NIHR) and the Medical Research
Council (MRC) programmes support high quality research of relevance and in
areas of high priority to patients and the NHS.  Details, including the
scope of the programmes and the arrangements for making applications for
support from them, are available on the respective websites at
[1]www.nihr.ac.uk and www.mrc.ac.uk

 

Funding awards are in all cases made after open, competitive, peer review.

Neither the NIHR nor the MRC usually ring-fences funds for expenditure on
particular topics: research proposals in all areas compete for the funding
available.  Both organisations welcome applications for support into any
aspect of human health and these are subject to peer review and judged in
open competition, with awards being made on the basis of the scientific
quality of the proposals made.

I hope this reply is helpful.

Yours sincerely,
 
James Shewbridge
Ministerial Correspondence and Public Enquiries
Department of Health

 

-------------------------------------------------------------------------------------------------------------------------

Please do not reply to this email. To contact the Department of Health,
please visit the [2]'Contact DH' section on the GOV.UK website.

 

show quoted sections

Incoming and outgoing e-mail messages are routinely monitored for
compliance with the Department of Health's policy on the use of electronic
communications. For more information on the Department of Health's e-mail
policy click here http://www.dh.gov.uk/terms

--------------------------------------------------------------------------

This email was scanned by the Symantec virus scanning service and was
certified virus free.
Communications may be automatically logged, monitored and/or recorded for
legal purposes.

References

Visible links
1. file:///C:/Users/~1~1D109.nihr.ac.uk__
2. https://www.gov.uk/government/organisati...

Do Not Reply,

Our ref: DE-1025761  

 

Dear  Mr Noe,
 
Thank you for your correspondence of 23 March about cannabis for medicinal
uses.  I have been asked to reply.

 

I should explain that the Freedom of Information Act only applies to
recorded information such as paper or electronic archive material.  As
your correspondence asked for general information, rather than requesting
recorded information or documentation, it did not fall under the
provisions of the Act.

 

Cannabis and its preparations, such as cannabis oil, which contain the
controlled substance tetrahydrocannabinol, are Class B controlled drugs
under the Misuse of Drugs Act 1971.  Cannabis is also subject to
international drug control under UN Conventions. 

 

The Misuse of Drugs Act 1971, and regulations made under the Act, allow
for controlled drugs to be used as medicines.  For example, Sativex, a
cannabis-based drug used to treat moderate to severe spasticity in
multiple sclerosis, was rescheduled following the granting of a marketing
authorisation to enable its prescribing and use as a medicine in the UK.

 

The National Institute for Health Research (NIHR) and the Medical Research
Council (MRC) programmes support high quality research of relevance and in
areas of high priority to patients and the NHS.  Details, including the
scope of the programmes and the arrangements for making applications for
support from them, are available on the respective websites at
[1]www.nihr.ac.uk and www.mrc.ac.uk

 

Funding awards are in all cases made after open, competitive, peer review.

Neither the NIHR nor the MRC usually ring-fences funds for expenditure on
particular topics: research proposals in all areas compete for the funding
available.  Both organisations welcome applications for support into any
aspect of human health and these are subject to peer review and judged in
open competition, with awards being made on the basis of the scientific
quality of the proposals made.

I hope this reply is helpful.

Yours sincerely,
 
James Shewbridge
Ministerial Correspondence and Public Enquiries
Department of Health

 

-------------------------------------------------------------------------------------------------------------------------

Please do not reply to this email. To contact the Department of Health,
please visit the [2]'Contact DH' section on the GOV.UK website.

 

show quoted sections

Incoming and outgoing e-mail messages are routinely monitored for
compliance with the Department of Health's policy on the use of electronic
communications. For more information on the Department of Health's e-mail
policy click here http://www.dh.gov.uk/terms

--------------------------------------------------------------------------

This email was scanned by the Symantec virus scanning service and was
certified virus free.
Communications may be automatically logged, monitored and/or recorded for
legal purposes.

References

Visible links
1. file:///C:/Users/~1~1D109.nihr.ac.uk__
2. https://www.gov.uk/government/organisati...